Documents in the NTIS Technical Reports collection are the results of federally funded research. They are directly submitted to or collected by NTIS from Federal agencies for permanent accessibility to industry, academia and the public.  Before purchasing from NTIS, you may want to check for free access from (1) the issuing organization's website; (2) the U.S. Government Printing Office's Federal Digital System website http://www.gpo.gov/fdsys; (3) the federal government Internet portal USA.gov; or (4) a web search conducted using a commercial search engine such as http://www.google.com.
Accession Number PB2013-101556
Title Axerion Therapeutics Generally Claimed Allowable Recovery Act Grant Costs.
Publication Date Sep 2012
Media Count 15p
Personal Author N/A
Abstract Axerion Therapeutics (the grantee), established in 2009, is a private biotechnology company focused on developing therapeutics for neurological diseases and injuries. NIH awarded the grantee a Recovery Act grant of $3 million for research related to neurological recovery from spinal cord injury and stroke. The grant budget period is April 15, 2010, through March 31, 2013. As of March 31, 2011, the grantee had claimed $950,844 under the grant; we reviewed the total amount claimed by the grantee. Our objective was to determine whether costs claimed by the grantee were allowable under the terms of the grant and applicable Federal regulations.
Keywords American Recovery and Reinvestment Act of 2009
Audits
Axerion Therapeutics
Cost analysis
Grants management
Inspectors general
Investigations
National government
Public Law 111-5
Recovery Act
US NIH


 
Source Agency Department of Health and Human Services, Washington, DC
NTIS Subject Category 44B - Agency Administrative & Financial Management
44S - Legislation & Regulations
70E - Research Program Administration & Technology Transfer
70B - Management Practice
Corporate Author Department of Health and Human Services, Washington, DC. Office of the Inspector General.
Document Type Technical report
Title Note N/A
NTIS Issue Number 1303
Contract Number N/A

Science and Technology Highlights

See a sampling of the latest scientific, technical and engineering information from NTIS in the NTIS Technical Reports Newsletter

Acrobat Reader Mobile    Acrobat Reader